[{"id":"29889af3-ae43-4e06-bdfc-acec22c139fb","acronym":"","url":"https://clinicaltrials.gov/study/NCT07198867","created_at":"2025-10-04T08:02:56.736Z","updated_at":"2025-10-04T08:02:56.736Z","phase":"Phase 1","brief_title":"A Study of A-CAR028 Treatment in Subjects With Relapsed or Refractory Acute Myeloid Leukemia","source_id_and_acronym":"NCT07198867","lead_sponsor":"First Affiliated Hospital of Zhejiang University","biomarkers":" CD33","pipe":" | ","alterations":" CD33 positive","tags":["CD33"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD33 positive"],"overall_status":"Recruiting","enrollment":" Enrollment 20","initiation":"Initiation: 09/30/2025","start_date":" 09/30/2025","primary_txt":" Primary completion: 12/30/2026","primary_completion_date":" 12/30/2026","study_txt":" Completion: 12/31/2027","study_completion_date":" 12/31/2027","last_update_posted":"2025-09-30"},{"id":"813d9f9f-1dff-4501-b8cd-864d0ba90be0","acronym":"CARAML","url":"https://clinicaltrials.gov/study/NCT05942599","created_at":"2023-07-12T15:08:59.274Z","updated_at":"2024-07-02T16:35:39.590Z","phase":"Phase 1","brief_title":"Base Edited CAR T Cells Against AML: Deep Conditioning Ahead of Allogeneic Stem Cell Transplantation","source_id_and_acronym":"NCT05942599 - CARAML","lead_sponsor":"Great Ormond Street Hospital for Children NHS Foundation Trust","biomarkers":" CD33","pipe":"","alterations":" ","tags":["CD33"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BE CAR33 T"],"overall_status":"Recruiting","enrollment":" Enrollment 10","initiation":"Initiation: 07/21/2023","start_date":" 07/21/2023","primary_txt":" Primary completion: 06/30/2025","primary_completion_date":" 06/30/2025","study_txt":" Completion: 06/30/2026","study_completion_date":" 06/30/2026","last_update_posted":"2023-08-21"},{"id":"a4138f09-df16-4b67-8543-1490d5f4430d","acronym":"TvT CAR7","url":"https://clinicaltrials.gov/study/NCT05397184","created_at":"2022-05-31T12:54:51.338Z","updated_at":"2024-07-02T16:35:43.998Z","phase":"Phase 1","brief_title":"Base Edited CAR7 T Cells to Treat T Cell Malignancies (TvT CAR7)","source_id_and_acronym":"NCT05397184 - TvT CAR7","lead_sponsor":"Great Ormond Street Hospital for Children NHS Foundation Trust","biomarkers":" CD7","pipe":"","alterations":" ","tags":["CD7"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BE CAR7 T"],"overall_status":"Recruiting","enrollment":" Enrollment 10","initiation":"Initiation: 04/19/2022","start_date":" 04/19/2022","primary_txt":" Primary completion: 04/01/2024","primary_completion_date":" 04/01/2024","study_txt":" Completion: 02/28/2025","study_completion_date":" 02/28/2025","last_update_posted":"2023-07-04"},{"id":"edeab902-2100-4815-8330-db8677913ca6","acronym":"","url":"https://clinicaltrials.gov/study/NCT05266950","created_at":"2022-03-04T15:53:28.701Z","updated_at":"2024-07-02T16:35:52.306Z","phase":"Phase 1","brief_title":"Safety and Efficacy Study of CI-135 CAR-T Cells in Subjects With Relapsed or Refractory Acute Myeloid Leukemia","source_id_and_acronym":"NCT05266950","lead_sponsor":"Beijing Boren Hospital","biomarkers":" FLT3","pipe":" | ","alterations":" FLT3 mutation • FLT3 expression","tags":["FLT3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e FLT3 mutation • FLT3 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • CI-135 CAR-T"],"overall_status":"Recruiting","enrollment":" Enrollment 7","initiation":"Initiation: 12/14/2021","start_date":" 12/14/2021","primary_txt":" Primary completion: 12/01/2024","primary_completion_date":" 12/01/2024","study_txt":" Completion: 12/01/2025","study_completion_date":" 12/01/2025","last_update_posted":"2023-03-27"},{"id":"299058dd-8801-4728-862b-b08c1fdf3994","acronym":"","url":"https://clinicaltrials.gov/study/NCT04627740","created_at":"2021-01-29T07:21:35.908Z","updated_at":"2024-07-02T16:36:38.710Z","phase":"Phase 1/2","brief_title":"Anti-ALPP CAR-T Cells Immunotherapy for Ovarian and Endometrial Cancer","source_id_and_acronym":"NCT04627740","lead_sponsor":"Xinqiao Hospital of Chongqing","biomarkers":" MSLN","pipe":" | ","alterations":" MSLN positive","tags":["MSLN"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MSLN positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • TC-A101"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 20","initiation":"Initiation: 12/01/2020","start_date":" 12/01/2020","primary_txt":" Primary completion: 12/31/2022","primary_completion_date":" 12/31/2022","study_txt":" Completion: 12/31/2023","study_completion_date":" 12/31/2023","last_update_posted":"2020-11-13"}]